Efficacy and Safety of Valsartan/Hydrochlorothiazide Combination Therapy in Patients With Hypertension
NCT00280540
·
clinicaltrials.gov ↗
PHASE4
Phase
COMPLETED
Status
648
Enrollment
INDUSTRY
Sponsor class
Conditions
Hypertension
Interventions
DRUG:
Valsartan/Hydrochlorothiazide
Sponsor
Novartis